These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11038750)

  • 41. Identities of P2 and P3 Residues of H-2Kb-Bound Peptides Determine Mouse Ly49C Recognition.
    Marquez EA; Kane KP
    PLoS One; 2015; 10(7):e0131308. PubMed ID: 26147851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An improved assembly assay for peptide binding to HLA-B*2705 and H-2K(k) class I MHC molecules.
    Tan L; Andersen MH; Elliott T; Haurum JS
    J Immunol Methods; 1997 Nov; 209(1):25-36. PubMed ID: 9448031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two complementary methods for predicting peptides binding major histocompatibility complex molecules.
    Gulukota K; Sidney J; Sette A; DeLisi C
    J Mol Biol; 1997 Apr; 267(5):1258-67. PubMed ID: 9150410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.
    Schumacher TN; Heemels MT; Neefjes JJ; Kast WM; Melief CJ; Ploegh HL
    Cell; 1990 Aug; 62(3):563-7. PubMed ID: 2199065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Class I histocompatibility molecule association with phosphorylated calnexin. Implications for rates of intracellular transport.
    Capps GG; Zúñiga MC
    J Biol Chem; 1994 Apr; 269(15):11634-9. PubMed ID: 8157696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.
    Fremont DH; Matsumura M; Stura EA; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):919-27. PubMed ID: 1323877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Empirical evaluation of a dynamic experiment design method for prediction of MHC class I-binding peptides.
    Udaka K; Mamitsuka H; Nakaseko Y; Abe N
    J Immunol; 2002 Nov; 169(10):5744-53. PubMed ID: 12421954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilization of the MHC class I (H-2Kb) purified molecule and its synthetic peptides for inhibition of Kb-specific suppressor T cells and their induction in vivo by the MHC peptides.
    Brondz BD; Anfalova TV; Pavlova LS; Pankratova EV; Kojich AG; Moshnikov SA
    Scand J Immunol; 1993 Jun; 37(6):627-33. PubMed ID: 8316760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A europium fluoroimmunoassay for measuring peptide binding to MHC class I molecules.
    Jensen PE; Moore JC; Lukacher AE
    J Immunol Methods; 1998 Jun; 215(1-2):71-80. PubMed ID: 9744749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ENPDA: an evolutionary structure-based de novo peptide design algorithm.
    Belda I; Madurga S; Llorà X; Martinell M; Tarragó T; Piqueras MG; Nicolás E; Giralt E
    J Comput Aided Mol Des; 2005 Aug; 19(8):585-601. PubMed ID: 16267689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strength in numbers: achieving greater accuracy in MHC-I binding prediction by combining the results from multiple prediction tools.
    Trost B; Bickis M; Kusalik A
    Immunome Res; 2007 Mar; 3():5. PubMed ID: 17381846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction: Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC-Peptide Binding Data Set.
    Cancer Immunol Res; 2019 Jul; 7(7):1221. PubMed ID: 31262774
    [No Abstract]   [Full Text] [Related]  

  • 53. Origins of antigenic peptides.
    Depraetere V
    Nat Cell Biol; 2000 May; 2(5):E75. PubMed ID: 10806488
    [No Abstract]   [Full Text] [Related]  

  • 54. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MHC/peptide binding studies indicate hierarchy of anchor residues.
    Deres K; Beck W; Faath S; Jung G; Rammensee HG
    Cell Immunol; 1993 Oct; 151(1):158-67. PubMed ID: 8402926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct binding of peptides to MHC class I molecules on living cells. Analysis at the single cell level.
    López JA; Luescher IF; Cerottini JC
    J Immunol; 1992 Dec; 149(12):3827-35. PubMed ID: 1460276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The interaction of antigenic peptides with the H-2Kd MHC class I molecule.
    Maryanski JL; Lüthy R; Romero P; Healy F; Drouet C; Casanova JL; Jaulin C; Kourilsky P; Corradin G
    Semin Immunol; 1993 Apr; 5(2):95-104. PubMed ID: 8504219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancing cytotoxic T cell responses with altered-peptide ligands.
    Zhao R; Collins EJ
    Arch Immunol Ther Exp (Warsz); 2001; 49(4):271-7. PubMed ID: 11726029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prediction and binding of a mutant p53 peptide to MHC class I molecule].
    Huang L; Luo L; Li M
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):249-52. PubMed ID: 11038750
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.